Glecaprevir/pibrentasvir for 8 weeks in treatment-naïve patients with chronic HCV genotypes 1–6 and compensated cirrhosis: The EXPEDITION-8 trial - Concepedia

Concepedia

Publication | Closed Access

Glecaprevir/pibrentasvir for 8 weeks in treatment-naïve patients with chronic HCV genotypes 1–6 and compensated cirrhosis: The EXPEDITION-8 trial

151

Citations

13

References

2019

Year

Robert S. Brown, Lino Rodrigues, Vladimir Chulanov, Wan‐Long Chuang, Humberto Aguilar, Gábor Horváth, E. Zuckerman, Bárbara Rosado Carrión, Federico Rodríguez-Pérez, Petr Urbánek,

Journal of Hepatology

References

	Year	Citations

Page 1